[图书][B] Biological, Diagnostic and Therapeutic Advances in Alzheimer's Disease

GM Ashraf, A Alexiou - 2019 - Springer
Alzheimer's disease (AD) is still a hardly curable disease with several symptoms of
behavioral and cognitive impairments. Besides the altered protein levels and the side effects …

Editorial [Hot Topic: Depression (Part 2)(Guest Editors: Ronald S. Duman and John H. Kehne)]

RS Duman, JH Kehne - … (Formerly Current Drug Targets-CNS & …, 2007 - ingentaconnect.com
Depressive illness is a devastating disorder that affects 18.8 million American adults (9.5%
of the adult population) and is the leading cause of disability in the US and other developed …

The neurobiology of depression: An integrated view

J Dean, M Keshavan - Asian journal of psychiatry, 2017 - Elsevier
Abstract Major Depressive Disorder (MDD) is one of the most common and debilitating
mental disorders; however, its etiology remains unclear. This paper aims to summarize the …

Alzheimer's disease: a scoping review of biomarker research and development for effective disease diagnosis

KG Faldu, JS Shah - Expert review of molecular diagnostics, 2022 - Taylor & Francis
Introduction Alzheimer's disease (AD) is regarded as the foremost reason for
neurodegeneration that prominently affects the geriatric population. Characterized by …

Integrated biomarkers for depression in Alzheimer's disease: A critical review

S Wenzler, C Knochel, C Balaban… - Current Alzheimer …, 2017 - ingentaconnect.com
Depression is a common neuropsychiatric manifestation among Alzheimer's disease (AD)
patients. It may compromise everyday activities and lead to a faster cognitive decline as well …

[HTML][HTML] Therapeutic targets and delivery challenges for Alzheimer's disease

P Desai, H Shete, R Adnaik, J Disouza… - World Journal of …, 2015 - wjgnet.com
Dementia, including Alzheimer's disease, the 21 st Century epidemic, is one of the most
significant social and health crises which has currently afflicted nearly 44 million patients …

Pathogenesis of depression: insights from human and rodent studies

C Ménard, GE Hodes, SJ Russo - Neuroscience, 2016 - Elsevier
Major depressive disorder (MDD) will affect one out of every five people in their lifetime and
is the leading cause of disability worldwide. Nevertheless, mechanisms associated with the …

Alzheimer's Disease Pathology and Assistive Nanotheranostic Approaches for Its Therapeutic Interventions

A Dey, S Ghosh, RL Rajendran… - International …, 2024 - search.proquest.com
Alzheimer's disease (AD) still prevails and continues to increase indiscriminately throughout
the 21st century, and is thus responsible for the depreciating quality of health and …

Innovative Therapeutic Strategies in Alzheimer's Disease: A Synergistic Approach to Neurodegenerative Disorders

SK Niazi, M Magoola, Z Mariam - Pharmaceuticals, 2024 - mdpi.com
Alzheimer's disease (AD) remains a significant challenge in the field of neurodegenerative
disorders, even nearly a century after its discovery, due to the elusive nature of its causes …

Alzheimer's disease: a review on the current trends of the effective diagnosis and therapeutics

AS Abdul Manap, R Almadodi, S Sultana… - Frontiers in Aging …, 2024 - frontiersin.org
The most prevalent cause of dementia is Alzheimer's disease. Cognitive decline and
accelerating memory loss characterize it. Alzheimer's disease advances sequentially …